Navigation Links
RayBiotech, Inc. Announces New Diagnostic Core Facility Partnering Program
Date:4/19/2012

NORCROSS, Ga., April 19, 2012 /PRNewswire/ -- RayBiotech, Inc. today announced that it has formally launched a partnering program for select diagnostic core facilities at academic and government research institutes in the United States and Canada.  Under the terms of the partnership program, core diagnostics facilities will be able to provide proprietary RayBiotech proteomic analysis services as a component of their current services offerings at no cost to the core facilities.  These services will be provided to select cores which emphasize biomarker and proteomic analysis to their affiliated researchers.  Services such as RayBiotech's Quantibody® characterization of biomarker expression will be emphasized, but all of RayBiotech's services portfolio will be available for pass-through to core clients, including ELISA and phosphorylation array testing.  The ultimate goal of this program will be to aid researchers in accelerating drug discovery, drug target validation and disease-related efforts with an emphasis on impacting cancer and other disease-specific research initiatives.  The program will be offered exclusively to cores in North America. 

Commenting on the new program, RayBiotech's President, COO and Co-founder, Rani Huang, said, "Since the founding of RayBiotech over ten years ago we have had numerous longstanding and productive relationships with academic and governmental research institutes.  This is our effort to give back to these partners and to establish new relationships with cutting-edge cores willing to adapt our platforms into their diagnostic services programs."

About RayBiotech, Inc.

RayBiotech (www.raybiotech.com) pioneered the development of antibody and protein array technologies and provides reliable high-throughput platforms for identifying disease mechanisms, screening and validation of novel biomarkers and identification of
'/>"/>

SOURCE RayBiotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Medivir Announces TMC435 in an Expanded Clinical Collaboration
2. Inspiration Biopharmaceuticals Announces Filing of Biologics License Application (BLA) for IB1001, a Recombinant Factor IX Product for People with Hemophilia B
3. CardioInsight Announces Appointment of Jim Bullock as Chairman of the Board of Directors
4. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
5. Custom Spine Announces 510K Clearance for Securis Cannulated Screw System
6. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
7. Islet Sciences Announces Receipt of $2.1 Million in Grant Support of Technology
8. ADVENTRX Announces Establishment of Regulatory Advisory Board
9. Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants
10. Syndax Pharmaceuticals Announces Start of Phase 1/2 Study of Entinostat in Combination with Lapatinib in HER2-Positive Metastatic Breast Cancer
11. GenVec Announces Research on Improved Vaccine Vectors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 Inflamax scientists worked closely ... to design the study, which will provide critical ... models used in the study of allergy treatments, ... Challenge (NAC) models. Although both the models are ... date no direct comparison between the allergic responses ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 PathoGenetix, Inc., ... bacterial strain typing, announced today that it has successfully ... E. coli strains obtained from the Centers for Disease ... Scanning™ (GSS™) technology. The findings are detailed in a ... the American Society for Microbiology in Denver on Monday. ...
(Date:5/20/2013)... Al Khaimah, UAE (PRWEB) May 21, 2013 ... private equity consultancy specializing in “game-changing” life science and ... of Ms. Dalia Dergham to its International Project Team. ... to bring even greater multi-cultural depth to Grace Century ... projects around the globe. , Ms. Dergham holds both ...
(Date:5/20/2013)...  (PSHR) Pacific Shore Holdings, Inc. a consumer ... broad range of product categories lines, today reports ... BlueWater Advisory Group, to provide strategic counsel and ... to direct the company,s outreach and investor awareness ... Matthew Mills , Pacific Shore Holdings, president ...
Breaking Biology Technology:Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2
... N.J., March 5 Palatin Technologies, Inc. (NYSE Alternext ... submitted on January 23, 2009 has been accepted by ... as the American Stock Exchange). As reported on December ... it was not in compliance with certain continued listing ...
... carbon nanotubes only billionths of a meter thick ... could make airplane skins and other products some ... cost. , Moreover, advanced composites reinforced with ... more electrically conductive than their counterparts without nanotubes, ...
... 4 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International Limited (NYSE: ... of medical devices worldwide announced today its selected ... year ended December 31, 2008.,The financial results reported ... monitoring business acquired from Datascope ("DPM") starting from ...
Cached Biology Technology:Palatin Technologies' Listing Compliance Plan Accepted by NYSE Alternext US 2MIT: 'Nanostitching' could strengthen airplane skins, more 2Mindray Announces 2008 Fourth Quarter and Full Year Results 2Mindray Announces 2008 Fourth Quarter and Full Year Results 3Mindray Announces 2008 Fourth Quarter and Full Year Results 4Mindray Announces 2008 Fourth Quarter and Full Year Results 5Mindray Announces 2008 Fourth Quarter and Full Year Results 6Mindray Announces 2008 Fourth Quarter and Full Year Results 7Mindray Announces 2008 Fourth Quarter and Full Year Results 8Mindray Announces 2008 Fourth Quarter and Full Year Results 9Mindray Announces 2008 Fourth Quarter and Full Year Results 10Mindray Announces 2008 Fourth Quarter and Full Year Results 11Mindray Announces 2008 Fourth Quarter and Full Year Results 12Mindray Announces 2008 Fourth Quarter and Full Year Results 13Mindray Announces 2008 Fourth Quarter and Full Year Results 14Mindray Announces 2008 Fourth Quarter and Full Year Results 15Mindray Announces 2008 Fourth Quarter and Full Year Results 16Mindray Announces 2008 Fourth Quarter and Full Year Results 17Mindray Announces 2008 Fourth Quarter and Full Year Results 18Mindray Announces 2008 Fourth Quarter and Full Year Results 19
(Date:5/20/2013)... Bacteria resistant to the antibiotic colistin are also ... human body, according to a study in ... American Society for Microbiology. Cross-resistance to colistin and ... the body against bacterial attack, could mean that ... saddled with a crippled immune response. Colistin is ...
(Date:5/20/2013)... Foundation (NSF) planning grant will help establish the Center ... of the University of Illinois at Urbana-Champaign and Worcester ... be devoted to research in drying moist, porous materials ... paper products; chemical products; textiles; and biopharmaceuticals," said Hao ... and human nutrition and the Illinois site director. , ...
(Date:5/19/2013)... have engineered a strain of electricity-producing bacteria that can ... and carbon dioxide as its sole source of carbon. ... their findings at the 113th General Meeting of the ... result of current production solely on hydrogen," says Amit ... his co-authors are part of the Lovley Lab Group ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
... -- University at Buffalo biophysicists have found a protein ... therapy for muscular dystrophy (MD). They have formed a ... to advance the drug to clinical trials. Fredrick ... University at Buffalo, and colleagues in his laboratory, discovered ...
... The sight of a cockroach scurrying for cover may be ... marvel, and is providing researchers at Oregon State University with ... world,s first legged robot that is capable of running effortlessly ... owe their success to what,s being learned from these insects ...
... LEADS: (top news in natural science) ... Volcanoes can be catastrophic. Lava flows and debris avalanches ... areas. Scientists from the USGS work with partners around ... use seismometers to detect and monitor very small earthquakes ...
Cached Biology News:Tarantula venom-based MD therapy to be advanced by UB scientists' biotech company 2Cockroaches offer inspiration for running robots 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7
ICAD / DFF45 (NT) Affinity Purified Polyclonal Antibody...
Acetyl CoA Carboxylase Antibody...
... Rabbit polyclonal to ZFP91 ( ... Antigen: Synthetic ... 280 of human ZFP91. (Note: ... Entrez ...
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Biology Products: